Given the association of redox imbalance with several neuropsychiatric disorders and the key role of the NRF2 pathway in counteracting oxidative stress, numerous studies continue to reveal the significant involvement of NRF2 in conditions such as major depressive disorder, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder (ADHD) [23,24]. This evidence concerns the gene NFE2L2 and schizophrenia.